-
Dubai, United Arab Emirates
-
Doha, Qatar
Dubai, United Arab Emirates
Doha, Qatar

Company Overview:
BGI Genomics is the world's leading integrated solutions provider of precision medicine and genomic sequencing services. As a subsidiary of BGI Group, the company offers comprehensive next-generation sequencing services, bioinformatics analysis, and multi-omics solutions for academic institutions, pharmaceutical companies, and healthcare providers globally. BGI combines advanced sequencing technology with expert data analysis for precision medicine applications.
Product Specialties & Applications:
BGI's comprehensive service portfolio includes NGS services for DNA sequencing, human whole genome sequencing (WGS) with high-resolution base-by-base genomic analysis, multi-omics solutions combining genomics with proteomics and metabolomics, bioinformatics analysis and interpretation, and precision medicine applications. BGI's WGS service detects complete genome sequences and provides comprehensive genomic profiling for research and clinical applications.
Alignment with Mega Life Science:
BGI's global genomic sequencing services and bioinformatics expertise enhance Mega Life Science's service portfolio. By partnering with BGI, Mega Life Science offers customers access to world-class sequencing capabilities, advanced data analysis platforms, and multi-omics solutions. This partnership enables comprehensive precision medicine and genomic research services for diverse laboratory and clinical applications.
Website: https://www.bgi.com/